Flagship Pioneering Inc. Seres Therapeutics, Inc. Transaction History
Flagship Pioneering Inc.
- $236 Million
- Q1 2025
A detailed history of Flagship Pioneering Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Flagship Pioneering Inc. holds 23,117,045 shares of MCRB stock, worth $172 Million. This represents 6.86% of its overall portfolio holdings.
Number of Shares
23,117,045
Previous 23,117,045
-0.0%
Holding current value
$172 Million
Previous $19.2 Million
15.67%
% of portfolio
6.86%
Previous 5.74%
Shares
5 transactions
Others Institutions Holding MCRB
# of Institutions
65Shares Held
39.5MCall Options Held
103KPut Options Held
53K-
Vanguard Group Inc Valley Forge, PA6.09MShares$45.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$13.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$12.1 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$10.8 Million0.0% of portfolio
-
Vontobel Holding Ltd.1.09MShares$8.09 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $924M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...